Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
117,273,296
-
Number of holders
-
106
-
Total 13F shares, excl. options
-
65,548,121
-
Shares change
-
-588,287
-
Total reported value, excl. options
-
$231,383,827
-
Value change
-
-$18,595,414
-
Put/Call ratio
-
71%
-
Number of buys
-
46
-
Number of sells
-
53
-
Price
-
$3.53
Institutional Holders of DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) as of Q1 2020
As of 31 Mar 2020 DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) had 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 65,548,121 shares of stock of the company.
Largest 10 holders included FEDERATED HERMES, INC., Bain Capital Life Sciences Investors, LLC, BlackRock Inc., VANGUARD GROUP INC, Chicago Capital, LLC, Avidity Partners Management LP, STATE STREET CORP, Bain Capital Public Equity Management II, LLC, BLAIR WILLIAM & CO/IL, and D. E. Shaw & Co., Inc..
This table shows 106 institutional shareholders of the security as of 31 Mar 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.